| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 4 | |
| #2 | EPO (European Patent Office) | 3 | |
| #3 | WIPO (World Intellectual Property Organization) | 3 | |
| #4 | Italy | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds | |
| #3 | Medical preparations | |
| #4 | Acyclic or carbocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Puricelli Guido | 11 |
| #2 | Rapposelli Simona | 9 |
| #3 | Sestito Simona | 9 |
| #4 | Daniele Simona | 6 |
| #5 | Martini Claudia | 6 |
| #6 | Calderone Vincenzo | 3 |
| #7 | Marracci Silvia | 1 |
| #8 | Natali Marco | 1 |
| #9 | Chiellini Grazia | 1 |
| #10 | Batistoni Renata | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020229014A1 | Novel thyromimetics with a biphenylmethane scaffold and their use | |
| US2021070730A1 | H2s-based therapeutic agents for the treatment of neurodegenerative diseases | |
| US2019160049A1 | 2-oxo-1,2-dihydropyridine-3-carboxamide compounds and their use as dual inhibitors of pdk1/aura | |
| EP3307726A1 | 2-oxo-1,2-dihydropyridine-3-carboxamide compounds and their use as inhibitors of pdk1 | |
| US2019022162A1 | Combination anticancer endowed with antitumor activity, comprising alkaloids of chelidonium majus |